[Role of tissue markers on diagnosis, prognosis and monitoring of prostate cancer].

CONCLUSIONS: Since prostate cancer is a heterogeneous disease, having a defined set of markers for early diagnosis, prognosis and follow-up, is clinically relevant. Some of these new markers can now be used to complement the conventional histopathologic diagnosis, as well as, to help already established parameters assessing prognosis. PMID: 25948798 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/25948798?dopt=Abstract

Source: Archivos Espanoles de Urologia - December 21, 2015 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research